Earth Science Tech (ETST) Total Non-Current Liabilities (2019 - 2025)
Earth Science Tech's (ETST) quarterly Total Non-Current Liabilities came in at $69305.0 in Q1 2025, down 52.37% YoY from $145509.0 in Q1 2024, and down 97.09% on a QoQ basis from $2.4 million in Q4 2024.
Earth Science Tech (ETST) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends
Earth Science Tech (ETST) has 3 years of Total Non-Current Liabilities data on file, last reported at $69305.0 in Q1 2025.
- Quarterly Total Non-Current Liabilities fell 52.37% year-over-year to $69305.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $69305.0 (down 52.37% YoY) and the FY2025 annual result came in at $69305.0, down 52.37% from the prior year.
- Total Non-Current Liabilities declined to $69305.0 in Q1 2025, from $2.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $2.4 million in Q4 2024 to a low of $69305.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.18 Bn | 43.22 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 43.96 Bn | 40.30 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 32.59 Bn | 30.92 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.90 Bn | 18.01 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.59 Bn | 15.20 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.95 Bn | 11.42 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.98 Bn | - | 334.00 Mn |
| 10 | Earth Science Tech | 34.80 Mn | 31.98 Mn | 6.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 69,305.00 |
| Dec 31, 2024 | 2.38 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 145,509.00 |
| Jun 30, 2019 | 3,734.00 |